A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...